94985-26-9 Usage
Uses
Used in Pharmaceutical Industry:
N-Benzyl-3-cyanoazetidine is used as a key intermediate in the synthesis of pharmaceutical drugs for its ability to contribute to the development of new molecules with biological activity. Its unique structure allows for the creation of compounds with potential therapeutic effects.
Used in Agrochemical Industry:
In the agrochemical sector, N-Benzyl-3-cyanoazetidine is utilized as a precursor in the production of agricultural chemicals, leveraging its reactivity to form compounds that can address various agricultural needs, such as pest control and crop protection.
Used in Research and Development:
N-Benzyl-3-cyanoazetidine is employed as a valuable compound in research and development for its potential to yield new molecules with significant biological activity. This makes it instrumental in advancing the fields of medicinal and agricultural chemistry through innovative synthesis and discovery of novel compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 94985-26-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,4,9,8 and 5 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 94985-26:
(7*9)+(6*4)+(5*9)+(4*8)+(3*5)+(2*2)+(1*6)=189
189 % 10 = 9
So 94985-26-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H12N2/c12-6-11-8-13(9-11)7-10-4-2-1-3-5-10/h1-5,11H,7-9H2
94985-26-9Relevant academic research and scientific papers
FACTOR XIA MACROCYCLIC INHIBITORS BEARING ALKYL OR CYCLOALKYL P2' MOIETIES
-
Page/Page column 123, (2017/02/24)
The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
Preparation of 1-benzylazetidine-3-ol derivatives
-
, (2008/06/13)
A process for the preparation of 1-substituted azetidin-3-ol derivatives of the formula: STR1 in which R1 represents a hydrogen atom or an alkyl, aryl or aralkyl group in which the alkyl moiety contains up to eight carbon atoms, by cyclizing a solution in triethylamine of an aminoalcohol of the formula: STR2 in which Hal represents a halogen atom and the use of such derivatives as intermediates for the preparation of azetidine-3-carboxylic acid derivatives.
Preparation of 1-benzylazetidin-3-ol
-
, (2008/06/13)
1-Benzylazetidin-3-ol, a precursor to 3-carboxyazetidine, is prepared by heating N-benzyl-3-amino-1-chloropropan-2-ol in an aqueous medium, optionally treating the resulting hydrochloride salt with an alkali metal base.
